A detailed history of Comerica Bank transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Comerica Bank holds 7,567 shares of LGND stock, worth $844,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,567
Previous 7,285 3.87%
Holding current value
$844,174
Previous $613,000 23.49%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$82.7 - $110.11 $23,321 - $31,051
282 Added 3.87%
7,567 $757,000
Q2 2024

Aug 15, 2024

SELL
$68.53 - $87.91 $38,171 - $48,965
-557 Reduced 7.1%
7,285 $613,000
Q1 2024

May 15, 2024

SELL
$68.64 - $89.2 $50,793 - $66,008
-740 Reduced 8.62%
7,842 $573,000
Q4 2023

Feb 14, 2024

BUY
$49.57 - $72.63 $33,509 - $49,097
676 Added 8.55%
8,582 $612,000
Q3 2023

Nov 21, 2023

BUY
$58.86 - $72.67 $465,347 - $574,529
7,906 New
7,906 $473,000
Q4 2022

Jan 26, 2023

SELL
$61.72 - $96.74 $165,409 - $259,263
-2,680 Reduced 21.85%
9,587 $0
Q3 2022

Oct 28, 2022

SELL
$0.01 - $107.56 $20 - $221,573
-2,060 Reduced 14.38%
12,267 $1.07 Million
Q2 2022

Aug 02, 2022

BUY
$74.52 - $117.06 $5,216 - $8,194
70 Added 0.49%
14,327 $1.34 Million
Q1 2022

Apr 27, 2022

BUY
$94.99 - $151.56 $21,372 - $34,101
225 Added 1.6%
14,257 $1.6 Million
Q4 2021

Feb 18, 2022

SELL
$127.69 - $165.85 $138,543 - $179,947
-1,085 Reduced 7.18%
14,032 $2.17 Million
Q3 2021

Nov 22, 2021

SELL
$102.33 - $144.73 $2.62 Million - $3.71 Million
-25,633 Reduced 62.9%
15,117 $2.11 Million
Q2 2021

Aug 26, 2021

SELL
$113.03 - $155.64 $162,989 - $224,432
-1,442 Reduced 3.42%
40,750 $5.35 Million
Q1 2021

Apr 28, 2021

SELL
$99.52 - $215.83 $1.3 Million - $2.81 Million
-13,041 Reduced 23.61%
42,192 $6.43 Million
Q4 2020

Jan 28, 2021

BUY
$80.55 - $106.05 $210,557 - $277,214
2,614 Added 4.97%
55,233 $5.49 Million
Q3 2020

Oct 30, 2020

BUY
$89.56 - $126.72 $1.66 Million - $2.35 Million
18,541 Added 54.41%
52,619 $5.02 Million
Q2 2020

Jul 31, 2020

SELL
$68.28 - $123.65 $164,145 - $297,254
-2,404 Reduced 6.59%
34,078 $3.81 Million
Q1 2020

May 01, 2020

BUY
$63.37 - $107.88 $270,526 - $460,539
4,269 Added 13.25%
36,482 $2.65 Million
Q4 2019

Feb 07, 2020

SELL
$96.94 - $113.59 $117,103 - $137,216
-1,208 Reduced 3.61%
32,213 $3.36 Million
Q3 2019

Oct 31, 2019

BUY
$86.25 - $120.16 $682,582 - $950,946
7,914 Added 31.03%
33,421 $3.33 Million
Q2 2019

Aug 02, 2019

SELL
$107.38 - $129.34 $191,780 - $231,001
-1,786 Reduced 6.54%
25,507 $0
Q1 2019

May 02, 2019

SELL
$105.93 - $142.47 $229,868 - $309,159
-2,170 Reduced 7.37%
27,293 $0
Q4 2018

Feb 06, 2019

SELL
$128.36 - $272.13 $105,383 - $223,418
-821 Reduced 2.71%
29,463 $3.42 Million
Q3 2018

Nov 01, 2018

SELL
$211.18 - $274.49 $437,564 - $568,743
-2,072 Reduced 6.4%
30,284 $5.54 Million
Q2 2018

Aug 01, 2018

SELL
$150.77 - $207.98 $119,862 - $165,344
-795 Reduced 2.4%
32,356 $7.18 Million
Q1 2018

May 01, 2018

BUY
$138.63 - $182.62 $520,001 - $685,007
3,751 Added 12.76%
33,151 $5.59 Million
Q4 2017

Feb 02, 2018

BUY
$128.36 - $147.04 $368,264 - $421,857
2,869 Added 10.81%
29,400 $4.82 Million
Q3 2017

Nov 06, 2017

BUY
$120.91 - $137.94 $3.21 Million - $3.66 Million
26,531
26,531 $3.79 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.